CPA
BIIB icon

Cowen Prime Advisors’s Biogen BIIB Stock Holding History

Cowen Prime Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,500
Closed -$470K – 192
2016
Q3 		$470K Buy
+1,500
New +$444K 0.21% 78
2014
Q3 		– Sell
-1,000
Closed -$315K – 302
2014
Q2 		$315K Buy
1,000
+400
+67% +$120K 0.12% 70
2014
Q1 		$184K Buy
+600
New +$190K 0.07% 100

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cowen Prime Advisors's BIIB Position: Q4 2016 in Review

Cowen Prime Advisors sold out of Biogen (BIIB) in Q4 2016, closing a stake of 1,500 shares — an estimated $470K sold.

Cowen Prime Advisors first reported a position in BIIB in Q1 2014 and held it in 3 quarters. The position peaked at $470K in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Cowen Prime Advisors reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Cowen Prime Advisors sold 1,500 Biogen shares in Q4 2016, an estimated $470K.
  • Cowen Prime Advisors first reported a position in Biogen in Q1 2014 and held it in 3 quarters.
  • Cowen Prime Advisors's Biogen position peaked at $470K in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.